Trial Library key facts
as of Oct 2026- Developer of clinical trial technology designed to improve health equity by expanding access to cancer precision medicine.
- Trial Library is valued at approximately $55.0M as of Oct 2026 (last reported valuation).
- It has raised $17.0M; the latest was Early Stage VC ($10.0M) in Dec 2025.
- Notable investors include Plug and Play Tech Center, Gaingels, Lux Capital, Karman Ventures, Sterling Road — 13 tracked in total.
- Status: Privately Held (backing).
Trial Library's last reported valuation, Dec 2025. Nothing priced has surfaced since.
- ·The complete investor list: 13 names
- ·Watch Trial Library: the Monday email on marks, rounds and moves
Trial Library funding rounds
No funding rounds for Trial Library are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Trial Library
13+Trial Library valuation
Trial Library's last reported valuation was $55 million in Dec 2025. No priced round, secondary trade or fund mark has surfaced since.
Trial Library investors
13 investors are on record for Trial Library, including Plug and Play Tech Center, Gaingels, Lux Capital and Karman Ventures. By type, the record holds 7 venture capital firms.
About Trial Library
Developer of clinical trial technology designed to improve health equity by expanding access to cancer precision medicine. The company's technology recognizes that inclusive research environments can answer questions that improve health outcomes and transform the standard of care by addressing inequities in discovery and access to cancer clinical trials, enabling customers to have assistance for accelerating equitable recruitment to clinical trials.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2022
- Employees
- 30
- Website
- triallibrary.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.